BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patel MM, York IA, Monto AS, Thompson MG, Fry AM. Immune-mediated attenuation of influenza illness after infection: opportunities and challenges. The Lancet Microbe 2021;2:e715-25. [DOI: 10.1016/s2666-5247(21)00180-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Chen YJ, Lin IF, Chuang JH, Huang HL, Chan TC. Influenza vaccination is associated with a reduced risk of invasive aspergillosis in high-risk individuals in Taiwan: a population-based cohort study. Emerg Microbes Infect 2023;12:2155584. [PMID: 36469743 DOI: 10.1080/22221751.2022.2155584] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kuruppu H, Wickramanayake WPRH, Jeewandara C, Peranantharajah D, Colambage HS, Perera L, Gomes L, Wijewickrama A, Ogg GS, Malavige GN. Adipokine levels and their association with clinical disease severity in patients with dengue. medRxiv 2023:2023. [PMID: 36711706 DOI: 10.1101/2023.01.06.23284269] [Reference Citation Analysis]
3 Yang J, Guo X, Zhang T, Wang Q, Zhang X, Yang J, Lai S, Feng L, Yang W. The Impact of Urbanization and Human Mobility on Seasonal Influenza in Northern China. Viruses 2022;14. [PMID: 36423173 DOI: 10.3390/v14112563] [Reference Citation Analysis]
4 Magiorkinis G. On the evolution of SARS-CoV-2 and the emergence of variants of concern. Trends in Microbiology 2022. [DOI: 10.1016/j.tim.2022.10.008] [Reference Citation Analysis]
5 Chemaitelly H, Nagelkerke N, Ayoub HH, Coyle P, Tang P, Yassine HM, Al-Khatib HA, Smatti MK, Hasan MR, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Duration of immune protection of SARS-CoV-2 natural infection against reinfection. J Travel Med 2022;29. [PMID: 36179099 DOI: 10.1093/jtm/taac109] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
6 Chemaitelly H, Nagelkerke N, Ayoub HH, Coyle P, Tang P, Yassine HM, Al-khatib HA, Smatti MK, Hasan MR, Al-kanaani Z, Al-kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-rahim HF, Nasrallah GK, Al-kuwari MG, Butt AA, Al-romaihi HE, Al-thani MH, Al-khal A, Bertollini R, Abu-raddad LJ. Duration of immune protection of SARS-CoV-2 natural infection against reinfection in Qatar.. [DOI: 10.1101/2022.07.06.22277306] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
7 Macdonald P. Getting an influenza vaccine is still important. Practice Nursing 2022;33:S5-S9. [DOI: 10.12968/pnur.2022.33.sup7.s5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Feikin DR, Abu-Raddad LJ, Andrews N, Davies MA, Higdon MM, Orenstein WA, Patel MK. Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization. Vaccine 2022;40:3516-27. [PMID: 35595662 DOI: 10.1016/j.vaccine.2022.04.069] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 22.0] [Reference Citation Analysis]
9 Patel M, Patel M. Increasing children's global access to COVID-19 vaccines. The Lancet 2022;399:2171-3. [DOI: 10.1016/s0140-6736(22)00884-4] [Reference Citation Analysis]
10 Price AM, Olson SM, Newhams MM, Halasa NB, Boom JA, Sahni LC, Pannaraj PS, Irby K, Bline KE, Maddux AB, Nofziger RA, Cameron MA, Walker TC, Schwartz SP, Mack EH, Smallcomb L, Schuster JE, Hobbs CV, Kamidani S, Tarquinio KM, Bradford TT, Levy ER, Chiotos K, Bhumbra SS, Cvijanovich NZ, Heidemann SM, Cullimore ML, Gertz SJ, Coates BM, Staat MA, Zinter MS, Kong M, Chatani BM, Hume JR, Typpo KV, Maamari M, Flori HR, Tenforde MW, Zambrano LD, Campbell AP, Patel MM, Randolph AG; Overcoming Covid-19 Investigators. BNT162b2 Protection against the Omicron Variant in Children and Adolescents. N Engl J Med 2022;386:1899-909. [PMID: 35353976 DOI: 10.1056/NEJMoa2202826] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 49.0] [Reference Citation Analysis]
11 Olson SM, Newhams MM, Halasa NB, Feldstein LR, Novak T, Weiss SL, Coates BM, Schuster JE, Schwarz AJ, Maddux AB, Hall MW, Nofziger RA, Flori HR, Gertz SJ, Kong M, Sanders RC, Irby K, Hume JR, Cullimore ML, Shein SL, Thomas NJ, Stewart LS, Barnes JR, Patel MM, Randolph AG; Pediatric Intensive Care Influenza Investigators . Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children. Clin Infect Dis 2022:ciab931. [PMID: 35024795 DOI: 10.1093/cid/ciab931] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
12 Koutsakos M, Lee WS, Reynaldi A, Tan H, Gare G, Kinsella P, Liew KC, Williamson DA, Kent HE, Stadler E, Cromer D, Khoury DS, Wheatley AK, Juno JA, Davenport MP, Kent SJ. Dynamics of immune recall following SARS-CoV-2 vaccination or breakthrough infection.. [DOI: 10.1101/2021.12.23.21268285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]